Subscribe To
Softbank clocks 6% revenue growth in q3
SoftBank Group Corp SFTBY reported a third-quarter Fy21 revenue growth of 6% Y/Y to ¥1.6 trillion....
February 8, 2022, 5:58 am
Softbank clocks 6% revenue growth in q3
SoftBank Group Corp SFTBY reported a third-quarter Fy21 revenue growth of 6% Y/Y to ¥1.6 trillion....
February 8, 2022, 5:58 am
Softbank clocks 6% revenue growth in q3
SoftBank Group Corp SFTBY reported a third-quarter Fy21 revenue growth of 6% Y/Y to ¥1.6 trillion....
February 8, 2022, 5:58 am
Bbq holdings: revisiting the investment thesis
BBQ continues to be active in the M&A field and recently bought Tahoe Joe's through a bankruptcy auction. BBQ delivered a solid third-quarter and is n...
February 7, 2022, 1:36 pm
Bbq holdings: revisiting the investment thesis
BBQ continues to be active in the M&A field and recently bought Tahoe Joe's through a bankruptcy auction. BBQ delivered a solid third-quarter and is n...
February 7, 2022, 1:36 pm
Bbq holdings: revisiting the investment thesis
BBQ continues to be active in the M&A field and recently bought Tahoe Joe's through a bankruptcy auction. BBQ delivered a solid third-quarter and is n...
February 7, 2022, 1:36 pm
Updated guidance and royalty pharma financing demolish short thesis for biocryst pharmaceuticals
Royalty Pharma and OMERS Capital Markets (OMERS) recently committed $350 million in non-dilutive funding for BioCryst. BioCryst generated $120 million...
February 7, 2022, 11:56 am
Updated guidance and royalty pharma financing demolish short thesis for biocryst pharmaceuticals
Royalty Pharma and OMERS Capital Markets (OMERS) recently committed $350 million in non-dilutive funding for BioCryst. BioCryst generated $120 million...
February 7, 2022, 11:56 am
Updated guidance and royalty pharma financing demolish short thesis for biocryst pharmaceuticals
Royalty Pharma and OMERS Capital Markets (OMERS) recently committed $350 million in non-dilutive funding for BioCryst. BioCryst generated $120 million...
February 7, 2022, 11:56 am
Catalyst pharma expects fy22 revenue beat consensus on continued recovery in macroeconomic, healthcare activity
Catalyst Pharmaceuticals Inc CPRX anticipates Q4 Fy21 sales of approximately $38 million (consensus ...
February 7, 2022, 10:27 am
Catalyst pharma expects fy22 revenue beat consensus on continued recovery in macroeconomic, healthcare activity
Catalyst Pharmaceuticals Inc CPRX anticipates Q4 Fy21 sales of approximately $38 million (consensus ...
February 7, 2022, 10:27 am
Catalyst pharma expects fy22 revenue beat consensus on continued recovery in macroeconomic, healthcare activity
Catalyst Pharmaceuticals Inc CPRX anticipates Q4 Fy21 sales of approximately $38 million (consensus ...
February 7, 2022, 10:27 am
Gates industrial q4 top-line misses street view; guides fy22 eps below consensus
Gates Industrial Corp PLC GTES reported fourth-quarter net sales growth of 2.7% year-over-year to $815.6 million and core revenue growth of 3.4%, m...
February 7, 2022, 10:08 am
Gates industrial q4 top-line misses street view; guides fy22 eps below consensus
Gates Industrial Corp PLC GTES reported fourth-quarter net sales growth of 2.7% year-over-year to $815.6 million and core revenue growth of 3.4%, m...
February 7, 2022, 10:08 am
Gates industrial q4 top-line misses street view; guides fy22 eps below consensus
Gates Industrial Corp PLC GTES reported fourth-quarter net sales growth of 2.7% year-over-year to $815.6 million and core revenue growth of 3.4%, m...
February 7, 2022, 10:08 am
/r e p e a t -- media advisory: cae's fy2022 third quarter financial results and conference call/
MONTREAL, Feb. 7, 2022 /PRNewswire/ - (NYSE: CAE) (TSX: CAE) – CAE will release its fiscal year 2022 third quarter results on Friday, February 11, ...
February 7, 2022, 9:09 am
/r e p e a t -- media advisory: cae's fy2022 third quarter financial results and conference call/
MONTREAL, Feb. 7, 2022 /PRNewswire/ - (NYSE: CAE) (TSX: CAE) – CAE will release its fiscal year 2022 third quarter results on Friday, February 11, ...
February 7, 2022, 9:09 am
/r e p e a t -- media advisory: cae's fy2022 third quarter financial results and conference call/
MONTREAL, Feb. 7, 2022 /PRNewswire/ - (NYSE: CAE) (TSX: CAE) – CAE will release its fiscal year 2022 third quarter results on Friday, February 11, ...
February 7, 2022, 9:09 am
Why cerence shares are plunging after q1 earnings?
Cerence Inc CRNC reported first-quarter Fy22 revenue growth of 0.8% year-on-year to $94.43 million, ...
February 7, 2022, 8:51 am
Why cerence shares are plunging after q1 earnings?
Cerence Inc CRNC reported first-quarter Fy22 revenue growth of 0.8% year-on-year to $94.43 million, ...
February 7, 2022, 8:51 am